Aryballe Technologies careers
Products :
From 2014 to 2017, the value proposition of the company will rely on 3 families of products:
1/ OdoraMap : a Smartphone application allowing the geo-localization, recording and sharing of nose smelled odors. Anticipated launch on the niche and consumer market: Q3-2014
2/ MonOlfact a set of small finely designed and manufactured objects, able to change color in the presence of specific odors. Anticipated launch on the niche and consumer market: Q2-2015
3/ NeOse (main product): A personal device to connect to smartphones and databases, able to recognize a wide spectrum of different odors. Anosmic market: Q1-2016 / C.E. & H.A. Q3-2016
Markets :
Niche Market: Anosmia (loss of the sense of smell) is a “neglected disease” which concerns 2% of the global population
Main Market: Up to 50 Consumer Electronics & Home Appliance application for the same core technology and Database. Products differentiations will be achieved by Smart-Phones’ apps.
From 2014 to 2017, the value proposition of the company will rely on 3 families of products:
1/ OdoraMap : a Smartphone application allowing the geo-localization, recording and sharing of nose smelled odors. Anticipated launch on the niche and consumer market: Q3-2014
2/ MonOlfact a set of small finely designed and manufactured objects, able to change color in the presence of specific odors. Anticipated launch on the niche and consumer market: Q2-2015
3/ NeOse (main product): A personal device to connect to smartphones and databases, able to recognize a wide spectrum of different odors. Anosmic market: Q1-2016 / C.E. & H.A. Q3-2016
Markets :
Niche Market: Anosmia (loss of the sense of smell) is a “neglected disease” which concerns 2% of the global population
Main Market: Up to 50 Consumer Electronics & Home Appliance application for the same core technology and Database. Products differentiations will be achieved by Smart-Phones’ apps.
Aryballe Technologies hasn't added any jobs yet
Get notified when Aryballe Technologies posts new jobs.
Delphine Pau
Sam Guilaume
CEO Movea
Sissel Tolaas
Thierry Livache
Tristan Rousselle
2013 - Founder & CEO of Aryballe Technologies
2000 - Founder & CEO of PX Therapeutics sold to Laboratoire Aguettant in 2012
1999 - PhD in Biotechnology
Veebot • Omaha • $103k – $159k • 5 days ago
Scintil Photonics • Old Toronto • 5 days ago
Haemonetics • Pennsylvania • $78k – $133k • 6 days ago
ARaymond • Rochester Hills • 1 week ago
Novocure • Scranton • $63k – $66k • 3 weeks ago

